Healthcare in New Jersey

in committee · New Jersey · Senate Jan 13, 2026

S 2543: Protects children from certain mandatory vaccinations as a condition of school attendance.

S 2543 prohibits New Jersey state, county, or municipal officials from requiring children to receive COVID-19 or HPV vaccinations as a condition for attending public primary or secondary schools. It also bans schools from asking about a child's vaccination status for these specific vaccines. The bill directly affects all children enrolled in New Jersey public schools and removes existing requirements tied to these two vaccines. It takes effect immediately upon enactment.

Topics ✗ Healthcare

Sub-Topics Public Health

in committee · New Jersey · Senate Jan 13, 2026

S 1308: "Pain-Capable Unborn Child Protection Act"; bans abortion 20 weeks or more after fertilization.

S 1308, the "Pain-Capable Unborn Child Protection Act," bans most abortions after 20 weeks of pregnancy based on fertilization timing. It directly affects pregnant people seeking abortions beyond this point and healthcare providers performing them. Exceptions allow abortions if the pregnancy endangers the woman’s life, or if the pregnancy resulted from rape (with reporting requirements) or incest involving a minor. The bill requires physicians to determine the unborn child’s probable age before an abortion and mandates neonatal care if a child survives an abortion under an exception. This legislation would take effect if passed, altering abortion access in New Jersey after 20 weeks.

Topics ✗ Healthcare

Sub-Topics Women's Health

in committee · New Jersey · Senate Jan 13, 2026

S 538: Enhances requirements for applicant seeking to locate substance use disorder treatment center within 500 feet of school.

S 538 requires applicants seeking to locate a substance use disorder treatment center within 500 feet of a school to notify local municipal and county planning officials before submitting their main license application. It mandates that applicants also request a resolution of local support from the municipal governing body and submit this resolution along with their license application. This bill directly affects treatment center applicants who wish to operate near schools, adding a community engagement step to the approval process. The requirement applies to new applications submitted after the bill's effective date, modifying existing licensing procedures under New Jersey law. The bill does not change the definition of treatment centers or apply to existing applications filed before enactment.

Topics ✗ Healthcare

Sub-Topics Substance Abuse

in committee · New Jersey · Senate Mar 16, 2026

S 301: Classifies 7 Hydroxymitragynine as Schedule I drug.

This bill adds 7-hydroxymitragynine (7-OH), a psychoactive compound found in Kratom, to New Jersey's Schedule I list of controlled substances. It directly affects anyone possessing, manufacturing, distributing, or using 7-OH in the state. Under the law, 7-OH would be classified as a substance with "high potential for abuse" and "no accepted medical use," making it illegal for non-medical purposes. Possession of 1 ounce or more would be a second-degree crime, while smaller amounts would be a third-degree crime under New Jersey's drug laws.

Topics ✗ Criminal Justice ✗ Healthcare

Sub-Topics Drug Policy

in committee · New Jersey · Senate Jan 13, 2026

S 1145: Prohibits DOH from issuing recommendations or regulations that are more stringent than recommendations or regulations issued by federal government.

This bill prohibits New Jersey's Department of Health (DOH) from creating health guidelines, rules, or regulations that are stricter than those set by federal agencies like the CDC or federal law. It directly affects the DOH by requiring all state health policies to match or be less strict than federal standards. The law applies to all administrative actions - including recommendations, directives, and regulations - and is retroactive to any existing state rules issued before the bill's effective date. This means the DOH must align its health policies with federal minimums, preventing New Jersey from implementing more protective measures.

Topics ✗ Healthcare

in committee · New Jersey · Senate Jan 13, 2026

S 1149: Prohibits mandatory vaccination against COVID-19 as condition of attending public K-12 schools.

This bill prohibits New Jersey state officials, including the Commissioner of Health, from requiring students to be vaccinated against COVID-19 to attend public K-12 schools. It directly affects public school students and families by removing a potential vaccination mandate for school attendance. The key provision bans state government entities from making SARS-CoV-2 vaccination a condition of enrollment or attendance in public primary or secondary schools. The law takes effect immediately upon passage, with no exceptions for school attendance requirements. It does not address other vaccination requirements or private school policies.

Topics ✗ Healthcare

Sub-Topics Public Health

in committee · New Jersey · Senate Jan 13, 2026

S 930: Repeals requirement that individuals maintain minimum essential health insurance coverage.

S 930 repeals New Jersey's requirement that individuals maintain minimum essential health insurance coverage, which previously imposed penalties for lack of coverage. The bill removes a provision from P.L.2018, c.31 that mandated state tax returns identify individuals without coverage and report this to the state. This directly affects New Jersey residents who would have faced penalties under the prior law for not having health insurance. The repeal eliminates the administrative requirement for tax returns to flag uncovered individuals and ends the state's enforcement of this mandate. The bill focuses solely on repealing this specific coverage requirement, not on creating new health programs.

Topics ✗ Healthcare

Sub-Topics Insurance

in committee · New Jersey · Senate Jan 13, 2026

SR 54: Urges U.S. Department of Health and Human Services and federal Centers for Medicare and Medicaid Services to reconsider implementation of new rules concerning organ procurement organizations.

This New Jersey Senate Resolution (SR 54) urges the U.S. Department of Health and Human Services and CMS to reconsider federal rules requiring organ procurement organizations (OPOs) to compete for service areas through bidding and face potential decertification based on performance metrics. The resolution argues these rules could disrupt the national organ donation system by forcing OPOs to bid for their existing geographic areas, increasing administrative burden, and potentially reducing organ transplants - disproportionately impacting racial minorities who already face lower transplant rates. It cites concerns that the rules ignore regional differences in healthcare access and could worsen existing inequities, rather than improving donation rates. As a non-binding resolution, SR 54 does not change policy but formally requests federal agencies delay or revise the CMS rule.

Topics ✗ Healthcare

Sub-Topics Medicaid Medicare

All healthcare bills